Purpose: To compare parametric maps, measured values and value distributions of cerebral blood volume (CBV) derived from 1) first pass T 1 -weighted dynamic contrast-enhanced (DCE) data (T 1 -CBV) and 2) T 2 *-weighted DCE data (T 2 *-CBV) in patients with intraaxial tumours. Materials and Methods: Sequential T 1 -and T 2 *-weighted DCE-MRI acquisitions were performed in 9 patients with cerebral neoplasms. CBV maps were calculated from T 2 *-weighted data using a conventional curve fitting technique and from T 1 -weighted first pass data using the recently described leakage profile model. Regions of interest were manually drawn around enhancing tumour tissue on matched slices and median tumour values and conspicuity indexes of CBV from the two techniques were compared. Pixel-by-pixel scattergrams of values in normal brain in a representative matched slice were produced for each case. 3D correlation renderings from both DCE-MRI datasets of a representative case were also produced for visual comparison. Results: Distortion of blood vessels and around susceptibility interfaces was evident on T 2 *-CBV but not on T 1 -CBV maps. Median ROI T 1 -and T 2 *-CBV measurements showed good correlation (r=0.667,p<0.05) in enhancing tumour, and there was no significant difference in conspicuity. Pixel-by-pixel comparison showed excellent correlation within normal brain (r=0.96,p<0.001). 3D renderings from T 1 -weighted data were visually superior. Conclusion: Leakage-free T 1 -CBV maps correlate well with conventionally generated T 2 *-CBV maps, both in terms of median measurements from tumour tissue and visual distribution of blood vessels. T 1 -CBV maps do not suffer from the susceptibility artefacts seen in T 2 *-CBV maps and offer higher through plane spatial resolution.
INTRODUCTION
The development of new blood vessels in tumours depends on the process of angiogenesis.
Under ischemic and hypoglycaemic challenge developing tumour cells produce cytokines and other vascular mediators which cause sprouting of endothelial cells from local blood vessels and a number of other physiological and developmental changes (1, 2) . These lead to the ingrowth of new blood vessels and vascularisation of the tumour. In general terms more aggressive, rapidly growing tumours will provide a stronger angiogenic stimulus and are characterised by increased microvascular density (MVD) on histological examination. A clear relationship between microvascular density and prognosis has been demonstrated for many tumour types which encouraged the development of non-invasive imaging based techniques that try to duplicate these measurements in vivo (3) (4) (5) . The best documented of these is the measurement of regional cerebral blood volume (CBV) using dynamic contrast enhanced MRI. Several groups have demonstrated a clear relationship between CBV and histological grade in cerebral glioma and in a number of other tumour types (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Areas of increased CBV within the enhancing components of gliomas correspond well with areas of increased fluorodeoxyglucose uptake on PET and with histological evidence of tumoral dedifferentiation (17) . As a result CBV maps are increasingly used in clinical assessment of patients with intracerebral tumours and appear to have application in tumour diagnosis, classification and particularly for the targeting of stereotactic surgical biopsy and post resection radiotherapy (18) (19) (20) (21) (22) .
The most commonly applied method for mapping CBV is based on dynamic contrast enhanced imaging using susceptibility (T 2 *) weighted images (DSCE-MRI) (19, 23, 24) .
This approach was first used to study the perfusion of normal cerebral capillary beds in grey 1 and white matter where the blood brain barrier (BBB) is intact and gadolinium based contrast agents can be assumed to act as purely intravascular markers. In these applications susceptibility based contrast mechanisms have the advantage over other MR techniques of increased signal to noise ratio in areas of low blood volume such as capillary beds. However susceptibility based techniques have significant disadvantages related to spatial distortion occurring in areas of paramagnetic variation and residual relaxivity effects in areas of extravascular contrast leakage. This has led several workers to try to derive CBV maps from T 1 weighted data (25) (26) (27) (28) (29) . Although these methods showed some promise they are not routinely used, largely because of their tendency to give rise to erroneously high estimates of CBV in areas of extravascular contrast leakage.
In 2000, Li et al. (17, 30, 31) described a novel method for the analysis of relaxivity (T 1 ) based dynamic contrast enhanced MRI (DRCE-MRI) which uses a shape-based analysis to decompose the dynamic contrast concentration time course data into intra-and extra-vascular components. One consequence of this analytical approach is the generation of an estimate of the intravascular contrast concentration time course curve that is free of leakage effects and therefore ideal for the calculation of leakage-free estimates of CBV. Examination of the method using Monte Carlo simulation techniques has shown that the representation of CBV values can be expected to be accurate across a wide range of CBV values (30) .
The purpose of the study presented here is to compare this novel DRCE-MRI technique with conventional DSCE-MRI approaches. The CBV maps generated from both methods have been compared in terms of image quality (spatial information, distortions, etc.), pixel value distributions within normal brain and measured values within intraaxial cerebral tumours.
MATERIALS AND METHODS
Nine patients (4 females and 5 males; mean age 48.2 years) with intra-axial cerebral neoplasms (see Table 1 ) were recruited into the study. All patients gave informed consent and the Central Manchester Healthcare NHS Trust and Salford Royal Hospitals NHS Trust medical ethical committees approved the protocols.
Image Acquisition
Imaging was performed on a 1.5 tesla MR system (Philips Medical Systems, Best, The Netherlands) using a birdcage head-coil.
Routine clinical T 1 -and T 2 -weighted anatomical imaging was performed in all patients prior to dynamic studies. Post-contrast T 1 -weighted volume images (TR 24 ms / TE 11 ms) were acquired at the end of the dynamic studies and used for qualitative comparison with parametric maps of CBV.
For acquisition of T 1 -weighted dynamic contrast-enhanced data, a 3D T 1 -FFE (T 1 fast field echo) scanning sequence was applied, with an image matrix of 128 128 pixels and 25 slices in the axial plane. The field of view used was 230 mm (square), with a slice thickness of 6 mm with 3 mm overlap (Fourier interpolation), resulting in an effective slice thickness of 3 mm. TR was set at 4.2 ms, and TE at 1.2 ms. Three pre-contrast data sets were acquired for the baseline T 1 calculation using flip angles of 2 , 10 and 35 . This was followed by a dynamic contrast-enhanced acquisition series at a flip angle of 35 , consisting of 120 scans with a temporal spacing of approximately 5 seconds. Gadolinium-based contrast agent (Gd-DTPA-BMA; Omniscan™, Amersham Health AS, Oslo, Norway) was injected as a bolus over 4 seconds at a dose of 0.1 mmol/kg of body weight.
Acquisition of T 2 *-weighted data was carried out immediately after completion of T 1 -weighted data acquisition so that pre-enhancement would minimize residual relaxivity effects ('T 1 shine through') in the dynamic data (32) . T 2 *-weighted (T 2 *W) dynamic contrastenhanced data was acquired using a multislice 2D T 2 *W-FEEPI (field echo EPI) sequence.
The image matrix was 128 128 pixels, with 9 slices in the axial plane. The field of view was again 230 mm (square), with slice thickness of 5 mm with 1 mm interslice gap, giving an effective slice thickness of 6 mm. TR was set at 440 ms, and TE at 30 ms. The dynamic contrast-enhanced series consisted of 52 scans at a flip angle of 35 and a temporal spacing of 1.8 s. A second dose of contrast agent (Gd-DTPA) was injected after the fifth dynamic scan using the same protocol described above.
For all scans the tumour was centred in the imaging volume, the imaging volume included the superior sagittal sinus to provide a vascular input function for analysis and the geometry of the T 2 *W acquisitions was selected from the preceding T 1 W acquisition so that images were spatially coincident with the central images in the T 1 W dynamic dataset.
Image Analysis
Dynamic contrast-enhanced T 1 -weighted data was analysed using the First Pass Leakage Profile (FPLP) method described by Li et al (17, 31) . This technique uses a shape analysis to decompose contrast concentration time course data into two separate components representing intra-and extra-vascular contrast agent, allowing calculation of CBV free from the effects of contrast leakage (T 1 -CBV), and of the transfer coefficient (K fp ) for the passage of contrast between the plasma and the extracellular extravascular space (EES).
T 2 *-weighted dynamic contrast-enhanced data was analysed using the technique described by Zhu et al. (10) , based on the techniques of Kassner et al. (32) . Multi-slice maps of rate of change of T 2 * ( R 2 *) were calculated from the T 2 *W-FEEPI dynamic data signals for each dynamic phase and a gamma variate model (33) was used to fit the first pass R 2 *(t) data.
Relative cerebral blood volume (rCBV) maps were calculated by pixel-by-pixel integration of the resulting gamma variate curves. Due to spatial distortions resulting from susceptibility effects in the T 2 *-weighted acquisition it was not possible to reliably apply automated coregistration of T 1 W and T 2 *W images.
Comparison of T 1 -CBV and T 2 *-CBV
Separate corresponding regions of interest (ROIs) were therefore manually defined on matched T 1 W and T 2 *W images. ROIs were drawn by an experienced neuroradiologist (TAP) and were defined on contrast enhanced images from the late phase dynamic acquisitions. ROI definition included all enhancing components of the tumour but excluded areas of non-enhancement. Calculated values of CBV from T 2 * weighted images were normalized to a value of 1 for a group of voxels (to avoid noise) with an intensity value of greater than 99% of the maximum (assumed to be 100% CBV) to obtain an estimate of absolute CBV. Median tumour CBV values from T 1 -CBV and T 2 *-CBV were calculated from each ROI, the values were plotted on a scattergram and the correlation between the values tested using Pearson's correlation coefficient. In addition direct visual comparison of T 1 -CBV and T 2 *-CBV maps was performed using a standardized colour map to aid comparison.
ROIs were also drawn on normal appearing white matter on both T 1 -CBV and T 2 *-CBV maps, and the mean (µ) and standard deviation ( ) from these were compared to values from the enhancing tumour ROIs in the same maps, to ascertain an index of tumour conspicuity using the following expression: A single corresponding slice was chosen from the T 1 -CBV and T 2 *-CBV maps of a representative case and manually registered. The T 1 -CBV map was then normalised to the T 2 *-CBV by finding the peak in the distribution of the logged CBV ratio over all voxels.
Actually, scattergrams were produced of the square-root of the CBV estimates from normal vascularised brain only in the two data sets over a range of 0 -0.6 in square-root CBV ( CBV ). The square root is taken for two reasons: first it produces voxel CBV estimates which have uniform error, and secondly, it expands the dynamic range of the data making it easier to see trends in the correlation between the two datasets. A second scattergram was obtained by taking the most similar value from the T 1 -CBV image to the T 2 *-CBV image corresponding to a half pixel linear interpolation in one of four directions (anterior, posterior, left, right) -a pixel shuffle technique. This is intended to account for slight non-rigidity between the two volumetric acquisitions and broadening of large blood vessels in T 2 * data due to susceptibility effects. representing the correlation coefficients. These volumes of correlation coefficients were rendered using Amira TM (TGS Template Graphics Software, Inc., USA). The quality of the individual volume renders from DSCE-MRI and DRCE-MRI were compared using a four point scale (0: non-diagnostic; 1: poor; 2: satisfactory; 3: excellent), evaluated by experienced neuroradiologists (AJ and TAP).
RESULTS
Parametric images from all patients were of good quality without motion artefacts. There was no evidence of residual relaxivity effects ('T 1 shine through') in the dynamic T 2 *-weighted data, which was tested as described previously (32) . Normal vasculature, such as the branches of the middle cerebral artery and the cerebral veins,
show high values of CBV as expected, and the enhancing portion of the tumour shows a heterogeneous distribution of CBV values. There is good differentiation of normal grey and white matter. Note that blood vessels appear much broader and smoother-edged on the T 2 *-CBV map than on the high resolution anatomical image. There is also considerable signal drop-out and distortion in the basal prefrontal cortex due to susceptibility artefact resulting from air in the paranasal sinuses. Fig. 1(d) is a T 1 -CBV map at the same location as Fig. 1(a) .
In contrast to Fig. 1 (b) the map shows improved demonstration of high spatial frequency features and anatomical details, particularly vascular structure, corresponding closely to the anatomical image ( Fig. 1(a) ). The signal-to-noise ratio in normal grey and white matter in hence visual identification of tumour tissue is equally good on both. The scatter plot in Figure 4 shows the pixel by pixel variation between T 1 -CBV and T 2 *-CBV in normal brain.
The plot illustrates a strong correlation between CBV estimates from the two techniques (r = 0.92, p < 0.001) and three additional features. First, estimates of T 1 -CBV extend down to zero, whereas those from T 2 *-CBV appear to be restricted to values above 0.01 CBV (0.1 in square-root CBV). This is entirely consistent with the expected susceptibility effects of enhancing capillary beds in T 2 * images. Secondly, the correlation is strong but with a broad random component. Thirdly, there is some evidence for an excess of large (> 0.2 CBV) values in T 2 *. Figure 5 is a pixel-by-pixel scattergram representing the same data using the pixel shuffle technique, which is intended to reduce differences due to small local spatial distortions. The results indicate that both approaches to CBV estimation are consistent (r = 0.96, p < 0.001) with the exception of spatial distortion effects in T 2 *-CBV, the differences being due to capillary enhancement occurring only in CBV values below those generally common in brain tissue.
3D volume renderings from DRCE-MRI and DSCE-MRI data are shown in Figure 6 .
Corresponding rendered mappings of correlation with an enhancing portion of tumour tissue ( Fig. 6(a) ) and with a major blood vessel ( Fig. 6(b) ) from DRCE-MRI data demonstrate high quality volumetric information about the location of the tumour and major vasculature in relation to the patient's head (the skull, scalp, ears and nose are clearly visible). 
DISCUSSION

Measurements of CBV based on DSCE-MRI techniques have clinical significance in a range
of disease states and appear to provide similar information to fluorodeoxyglucose PET scanning concerning the presence and distribution of tumour tissue heterogeneity (34) . In patients with stroke, regional changes in CBV correlate poorly with local flow changes and far better with changes in local water diffusion characteristics and appear to reflect local autoregulatory status (35, 36) .
The generation of quantitative CBV maps has traditionally been based on T 2 * weighted sequences utilizing susceptibility contrast mechanisms. DSCE-MRI approaches were initially used because the susceptibility contrast mechanism gives a superior signal-to-noise ratio in low density capillary beds such as are seen in normal brain (23, 37, 38) . In addition, the signal changes seen on T 2 * weighted images in normal brain are less affected by contrast in large vessels, so that DSCE-MRI acquisitions were classically considered as "capillary weighted". These properties can be considered beneficial for the study of normal brain tissue where the CBV is low and the blood brain barrier is intact.
However, the use of DSCE-MRI techniques to measure CBV in cerebral tumours is associated with a number of inherent disadvantages. High sensitivity to susceptibility effects is associated with distortions around susceptibility interfaces, which will include the air in the paranasal sinuses and petrous bone and structures containing a high concentration of contrast in enhanced images. Secondly, leakage of contrast due to blood brain barrier breakdown, which is an intrinsic feature of malignant cerebral tumours, will cause competing relaxivity effects on the observed signal changes which will lead to erroneous underestimation of CBV.
In practice, these effects are compensated by decreasing the T 1 sensitivity of the sequences or by contrast pre-enhancement to saturate T 1 based signal change effects as was performed in the current study (32) . Thirdly, T 2 * weighted images rely on the use of long echo times (TE) to maintain their T 2 sensitivity which reduces the size of the sampling matrix and number of slices which can be acquired within the required temporal resolution (approximately 2 seconds). This can be tackled by the use of echo planar imaging (EPI) acquisitions which greatly enhance acquisition speed but which will impose additional and unpredictable spatial distortions into the image making them potentially unsuitable for spatially-sensitive procedures such as surgical planning applications. These effects can be reduced to some extent by the use of segmented EPI acquisitions and temporal resolution can be maintained by the use of echo shifting techniques in sequences such as PRESTO which also uses a volume acquisition to maintain signal to noise ratio (39) .
In view of the problems associated with DSCE-MRI techniques several groups have attempted to use relaxivity based dynamic images (DRCE-MRI) to derive estimates of CBV.
The potential advantages of this approach include the lack of spatial distortion associated with T 1 W images and the potential for fast 3D imaging approaches without the need for EPI collections. The major problem with DRCE-MRI in enhancing tissues is the inability to separate the effects of intravascular and extravasated contrast on the observed signal change.
This means that signal changes in areas of high capillary permeability will result to a large degree from contrast leakage and estimates of CBV will therefore be erroneously high.
Despite this disadvantage, Hacklander's group in the late nineties described the use of DRCE-MRI in cerebral tumours in a series of publications (25) (26) (27) (28) . This group dealt with the leakage problem by assuming that contrast leakage is so slow that it can be ignored over the time course of a single passage of a contrast bolus. They stated that: "gadopentate dimeglumine can almost be regarded to be an intravascular contrast agent, even in cases of a disturbed blood brain barrier". They concluded that T 1 -CBV measurements could be used in enhancing tissues. However, it is interesting to note that they were unable to demonstrate significant differences between grade III and grade IV glioma even though this has been shown by several groups using susceptibility based techniques (10, 11, 29) . In addition, careful comparison of the results from the T 2 * and T 1 based techniques shows systematic overestimation of T 1 -CBV in tumours with high values (Figure 7 in (28) In practice, as described above, the tendency for T 2 *-CBV maps to underestimate CBV in areas of contrast leakage can be minimised by a variety of acquisition strategies which are discussed in detail by Kassner et al. (32) , so that the major residual disadvantages of T 2 * based methods are the distortion associated with susceptibility effects and the restrictions on imaging time. The sequences used here represent a compromise between spatial resolution and susceptibility sensitivity using a segmented EPI acquisition protocol to reduce scan time whilst minimising the degree of spatial distortion. Despite this we were only able to collect 9
slices of data at a matrix of 128 2 within the 1.8-second time resolution required and the resultant images show significant distortions both at tissue-air interfaces and more importantly, around large vessels. Further improvements in gradient performance mean that our current system can collect 12 slices within the same time window but, in reality, the use of T 2 * EPI sequences is problematic. The use of optimized T 2 * based sequences such as PRESTO offer the opportunity to improve on this performance by combining echo shifted, segmented EPI collection and volume acquisition techniques in order to maximize temporal and spatial resolution whilst limiting sensitivity to susceptibility artefacts and distortions.
Although these sequences are still not widely available and we have not used them in this study our experience with them indicates that the improvements in susceptibility distortion are relatively limited and spatial distortion remains a significant problem (32, 40) .
The use of DRCE-MRI offers significant theoretical advantages allowing increased sampling speed and therefore greater spatial resolution and coverage. More importantly there is no susceptibility spatial distortion associated with standard T 1 W sequences. A third potential advantage is the ability to use reduced contrast doses compared to DSCE-MRI although we have not explored that aspect in this study (28, 29) . The major problem with DRCE-MRI is that the signal changes resulting from intravascular contrast and from extravasated contrast occur in the same direction and, since they result from the same physical contrast mechanism, cannot be separated by modifications of the acquisition technique. We have used the first pass leakage profile model described by Li et al. (31, 41) to separate these effects and to generate leakage free T 1 -CBV maps. This analysis technique decomposes the contrast concentration time course data from DRCE-MRI into two components: the first due to intravascular contrast agent, and the second due to contrast agent leakage into the extravascular extracellular space. The technique works by using a constrained shape model of each component and decomposing the data to produce the optimised fit to these constraints.
Although the technique was designed to produce estimates of transendothelial contrast transfer coefficient (K trans (42) , or more specifically K fp (43) ) which are free of intravascular contrast effects it also allows calculation of leakage-free CBV maps. The theoretical advantages in terms of temporal resolution, tissue coverage and freedom from image distortion have been the subject of the present study. However, it is equally important to know that CBV estimates from DRCE-MRI provide comparable biological information to those derived from conventional DSCE-MRI techniques. This study has confirmed that this is the case with close correlation between median values and also excellent pixel-by-pixel agreement, particularly when spatial distortion effects are reduced. The advantages of T 1 techniques allow confident use of parametric maps for image guided surgical procedures and radiotherapy planning without any risk of error due to spatial distortion. The ability to increase coverage and through plane resolution also allows direct 3D visualisation of these data sets with better practical quality than with DSCE-MRI.
In conclusion we would recommend the routine use of T 1 -weighted DCE-MRI for the measurement of CBV in cerebral tumours. The technique allows larger sampling volumes, removes the risk of significant spatial distortion, provides biologically equivalent data to conventional T 2 *-weighted DCE-MRI methods and has the added advantage of providing high-quality maps of the transfer coefficient. 
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